Adma Biologics Stock Future Price Prediction

ADMA
 Stock
  

USD 2.43  0.17  7.52%   

Adma Biologics stock price prediction is an act of determining the future value of Adma Biologics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Adma Biologics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Adma Biologics and does not consider all of the tangible or intangible factors available from Adma Biologics' fundamental data. We analyze noise-free headlines and recent hype associated with Adma Biologics, which may create opportunities for some arbitrage if properly timed.
Please continue to Adma Biologics Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Adma Biologics based on different types of headlines from major news networks to social media. The Adma Biologics stock price prediction module provides an analysis of price elasticity to changes in media outlook on Adma Biologics over a specific investment horizon.Using Adma Biologics hype-based prediction, you can estimate the value of Adma Biologics from the perspective of Adma Biologics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Adma Biologics using Adma Biologics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Adma Biologics using crowd psychology based on the activity and movement of Adma Biologics' stock price.

Adma Biologics Implied Volatility

    
  121.05  
Adma Biologics' implied volatility exposes the market's sentiment of Adma Biologics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Adma Biologics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Adma Biologics stock will not fluctuate a lot when Adma Biologics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Adma Biologics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Adma Biologics to buy its stock at a price that has no basis in reality. In that case, they are not buying Adma Biologics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Adma Biologics after-hype prediction price

    
  $ 2.43  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Adma Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Adma Biologics in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.163.256.89
Details
4 Analysts
Consensus
LowTarget PriceHigh
3.005.7010.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Adma Biologics. Your research has to be compared to or analyzed against Adma Biologics' peers to derive any actionable benefits. When done correctly, Adma Biologics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Adma Biologics.

Adma Biologics After-Hype Price Prediction Density Analysis

As far as predicting the price of Adma Biologics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Adma Biologics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Adma Biologics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Adma Biologics Estimiated After-Hype Price Volatility

In the context of predicting Adma Biologics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Adma Biologics' historical news coverage. Adma Biologics' after-hype downside and upside margins for the prediction period are 0.12 and 6.07, respectively. We have considered Adma Biologics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 2.43
2.43
After-hype Price
6.07
Upside
Adma Biologics is unstable asset. Analysis and calculation of next after-hype price of Adma Biologics is based on 3 months time horizon.

Adma Biologics Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Adma Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adma Biologics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Adma Biologics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.27  3.61  0.00    0.39  3 Events / Month3 Events / MonthIn about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.432.430.00 
36,100  

Adma Biologics Hype Timeline

Adma Biologics is presently traded for 2.43. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.39. Adma Biologics expected not to react to the next headline with the price going to stay at about the same level and average media hype impact volatility of over 100%. The immediate return on the next newsis expected to be very small whereas the daily expected return is presently at 0.27%. The volatility of relative hype elasticity to Adma Biologics is about 251.74%. The volatility of related hype on Adma Biologics is about 251.74% with expected price after next announcement by competition of 2.04. About 69.0% of the company shares are held by institutions such as insurance companies. The book value of Adma Biologics was presently reported as 0.84. The company recorded a loss per share of 0.88. Adma Biologics had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 3 days.
Please continue to Adma Biologics Basic Forecasting Models to cross-verify your projections.

Adma Biologics Related Hype Analysis

Having access to credible news sources related to Adma Biologics' direct competition is more important than ever and may enhance your ability to predict Adma Biologics' future price movements. Getting to know how Adma Biologics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Adma Biologics may potentially react to the hype associated with one of its peers.

Adma Biologics Additional Predictive Modules

Most predictive techniques to examine Adma Biologics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Adma Biologics using various technical indicators. When you analyze Adma Biologics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Adma Biologics Predictive Indicators

The successful prediction of Adma Biologics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Adma Biologics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Adma Biologics based on analysis of Adma Biologics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Adma Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Adma Biologics's related companies.

Story Coverage note for Adma Biologics

The number of cover stories for Adma Biologics depends on current market conditions and Adma Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Adma Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Adma Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Adma Biologics Short Properties

Adma Biologics' future price predictability will typically decrease when Adma Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Adma Biologics often depends not only on the future outlook of the potential Adma Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adma Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out14.63%
Short Percent Of Float15.24%
Float Shares159.76M
Shares Short Prior Month25.54M
Average Daily Volume Last 10 Day4.54M
Average Daily Volume In Three Month2.63M
Date Short Interest15th of July 2022
Please continue to Adma Biologics Basic Forecasting Models to cross-verify your projections. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for analysis

When running Adma Biologics price analysis, check to measure Adma Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adma Biologics is operating at the current time. Most of Adma Biologics' value examination focuses on studying past and present price action to predict the probability of Adma Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Adma Biologics' price. Additionally, you may evaluate how the addition of Adma Biologics to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Adma Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adma Biologics. If investors know Adma Biologics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adma Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Adma Biologics is measured differently than its book value, which is the value of Adma Biologics that is recorded on the company's balance sheet. Investors also form their own opinion of Adma Biologics' value that differs from its market value or its book value, called intrinsic value, which is Adma Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adma Biologics' market value can be influenced by many factors that don't directly affect Adma Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adma Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Adma Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adma Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.